Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER.

J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22.

2.

Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.

Uren A, Toretsky JA.

Future Oncol. 2005 Aug;1(4):521-8. Review.

PMID:
16556028
3.

Periosteal Ewing sarcoma family of tumors of the femur confirmed by molecular detection of EWS-FLI1 fusion gene transcripts: a case report and review of the literature.

Hakozaki M, Hojo H, Tajino T, Yamada H, Kikuta A, Ito M, Sano H, Mochizuki K, Akaihata M, Kikuchi S, Abe M.

J Pediatr Hematol Oncol. 2007 Aug;29(8):561-5. Review.

PMID:
17762498
4.

Molecular confirmation of Ewing sarcoma.

Dagher R, Pham TA, Sorbara L, Kumar S, Long L, Bernstein D, Mackall C, Raffeld M, Tsokos M, Helman L.

J Pediatr Hematol Oncol. 2001 May;23(4):221-4. Review.

PMID:
11846300
5.

EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.

Ban J, Siligan C, Kreppel M, Aryee D, Kovar H.

Adv Exp Med Biol. 2006;587:41-52. Review.

PMID:
17163154
6.

Ewing sarcoma family of tumors.

Khoury JD.

Adv Anat Pathol. 2005 Jul;12(4):212-20. Review.

PMID:
16096383
7.

Ewing's sarcoma: standard and experimental treatment options.

Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA.

Curr Treat Options Oncol. 2009 Apr;10(1-2):126-40. doi: 10.1007/s11864-009-0104-6. Epub 2009 Jun 17. Review.

PMID:
19533369
8.

Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Erkizan HV, Uversky VN, Toretsky JA.

Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. Review.

9.

Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Lessnick SL, Ladanyi M.

Annu Rev Pathol. 2012;7:145-59. doi: 10.1146/annurev-pathol-011110-130237. Epub 2011 Sep 19. Review.

10.

Novel approaches for the management of patients with Ewing sarcoma.

Avigad S, Yaniv I.

Future Oncol. 2006 Oct;2(5):659-65. Review.

PMID:
17026457
11.

Ewing's sarcoma cancer stem cell targeted therapy.

Todorova R.

Curr Stem Cell Res Ther. 2014 Jan;9(1):46-62. Review.

PMID:
24294922
12.

The potential for molecular therapeutic targets in Ewing's sarcoma.

McAllister NR, Lessnick SL.

Curr Treat Options Oncol. 2005 Nov;6(6):461-71. Review.

PMID:
16242051
13.

Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity.

Sanchez G, Delattre O, Auboeuf D, Dutertre M.

Cell Cycle. 2008 Aug;7(15):2299-305. Epub 2008 Jun 17. Review.

PMID:
18677114
14.

Pediatric malignancies provide unique cancer therapy targets.

Uren A, Toretsky JA.

Curr Opin Pediatr. 2005 Feb;17(1):14-9. Review.

PMID:
15659957
15.

Dilemmas associated with congenital ewing sarcoma family tumors.

Kim SY, Tsokos M, Helman LJ.

J Pediatr Hematol Oncol. 2008 Jan;30(1):4-7. doi: 10.1097/MPH.0b013e31815cf71f. Review. No abstract available.

16.

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Juergens H, Oberlin O.

J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24. Review.

PMID:
26304893
17.

Update in treatment and targets in Ewing sarcoma.

Cote GM, Choy E.

Hematol Oncol Clin North Am. 2013 Oct;27(5):1007-19. doi: 10.1016/j.hoc.2013.07.001. Epub 2013 Aug 3. Review.

PMID:
24093173
18.

[PNET/Ewing tumours: current treatments and future perspectives].

Marec-Bérard P, Chotel F, Claude L.

Bull Cancer. 2010 Jun;97(6):707-13. doi: 10.1684/bdc.2010.1120. Review. French.

PMID:
20497910
19.

EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.

Cidre-Aranaz F, Alonso J.

Front Oncol. 2015 Jul 20;5:162. doi: 10.3389/fonc.2015.00162. eCollection 2015. Review.

20.

Targeted therapies for advanced Ewing sarcoma family of tumors.

Jiang Y, Ludwig J, Janku F.

Cancer Treat Rev. 2015 May;41(5):391-400. doi: 10.1016/j.ctrv.2015.03.008. Epub 2015 Mar 27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk